On September 30, 2024, Empery Asset Management, LP made a notable addition to its investment portfolio by acquiring 4,000,000 shares of Elevation Oncology Inc.
The transaction was executed at a price of $0.5999 per share, representing a significant increase in the firm's stake in the biotechnology company.
This strategic acquisition by a prominent asset management firm signals a vote of confidence in Elevation Oncology's pipeline and long-term potential.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.